Join our research network for opportunities to connect with health policy makers

Join RADAR

The Sax Institute offers opportunities for researchers to work with health policy makers in a number of ways. These include commissioning rapid reviews, and bringing researchers and policy makers together to collaborate, innovate and exchange ideas through different forums.

Complete the form below to join our Radar database of researchers. We will then notify you when opportunities arise to connect with policy makers and work with us.

Seeking expressions of interest from researchers

Current expressions of interest are posted below and emailed to our Radar database which you can join below.

The Sax Institute is commissioning a rapid review of existing evidence on the short and long-term effects of prenatal cannabis exposure.  

This review will inform the development of simple communication material for:

  • non-expert clinicians such as frontline AOD and maternity staff, and
  • pregnant women and women of childbearing age who use cannabis.

An interdisciplinary team of researchers to complete this review is desirable. The disciplines of interest are:

  • Addiction medicine
  • Gynaecology/obstetrics
  • Neonatology
  • Paediatrics

Expressions of interest close 14 December 2022.

Evidence Check Review

The review will address the following questions:

Question 1

For infants prenatally exposed to cannabis, what are the effects of cannabis on foetal development, neonatal withdrawal, birth outcomes, infant development and child development (up to 16 years age)?

Question 2

For women who use cannabis in pregnancy, what are the effects of cannabis on antenatal/obstetric outcomes?

A draft (complete) report for this Evidence Check review is required by 24 February 2023, and the final report by 22 March 2023.

If you would like a copy of the project brief for this review, please contact by email: eileen.goldberg@saxinstitute.org.au. Please use ‘EOI: 23-MOH-04_Impact of cannabis use during pregnancy’ in the subject line.

If this review is not of interest to you, please forward this opportunity to colleagues working in this area.

The Sax Institute is commissioning a rapid review of existing evidence to understand the experience of GPs and their patients regarding how sensitive preventive health issues are raised and discussed in the general practice setting.

This review will inform the development of an intervention strategy to improve the way preventive health issues are raised and discussed with patients in general practice. Expressions of interest close 11 December 2022.

The health issues of specific interest for this review are STIs, HIV, hepatitis, overweight and obesity, domestic violence, alcohol and other drugs, mental health, smoking and vaping cessation.

The review will address the following questions:

Question 1

From adult patients’ perspectives, what is known about raising and discussing sensitive preventive health issues with a general practitioner, including:

  1. What preventive health issues are considered sensitive by patients?
  2. What are the reasons that patients consider some preventive health issues to be sensitive?
  3. What factors do patients consider improves communication with a general practioner about sensitive preventive health issues?
  4. What factors do patients consider hinders communication with a general practitioner about sensitive preventive health issues?

Question 2

What are general practitioners’ perspectives on raising and discussing sensitive preventive health issues with patients, with regard to:

  1. Their role in raising sensitive health issues as part of the consultation
  2. Understanding of patient perspectives about sensitive health issues
  3. Barriers to raising and discussing sensitive health issues
  4. Enablers that support raising and discussing sensitive health issues

Question 3:

What approaches or factors have been shown to be effective in raising and discussing sensitive preventive health issues with adult patients by general practitioners?

A draft (complete) report for this Evidence Check review is required by 20 February 2023, and the final report by 23 March 2023.

If you would like a copy of the project brief for this review, please contact by email: eileen.goldberg@saxinstitute.org.au. Please use ‘EOI: 23-CPH-03 Sensitive health issues in primary care’ in the subject line.

If this review is not of interest to you, please forward this opportunity to colleagues working in this area.

The Sax Institute is commissioning an Evidence Check review on screening and assessment tools on health and psychosocial wellbeing for children and young people aged 5 – 18 years. Expressions of interest close at 5pm AEDT on 14 December 2021.

The review will address the following questions:

  1. What validated health screening tools for children and young people aged 5 to 12 years have been found to be effective?
  2. What validated health screening tools for children and young people aged 12-18 years have been found to be effective?
  3. For the screening tools in Questions 1 and 2 which were implemented and evaluated, how were the assessments, systems or tools used in clinical practice and what barriers and enablers have been described?

A draft (complete) report is required by 2 March 2022 and the final report by 7 April 2022

If you would like a copy of the project proposal for this review on screening and assessment tools on health and psychosocial wellbeing for children and young people aged 5 – 18 years, please contact by email: deshanie.rawlings@saxinstitute.org.au.

If this review is not of interest to you, please forward this opportunity to colleagues working in this area.

Learn more about Evidence Check